(Total Views: 349)
Posted On: 12/29/2020 4:43:19 PM
Post# of 653
$RLFTF Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms
"The clinical trial will continue to enroll patients through the anticipated early Q1 2021 announcement of top line data in order to amass as large a safety database as possible.
To date, no drug-related Serious Adverse Event has been reported in any of the ongoing studies of RLF-100, which is consistent with the absence of toxicity seen in extensive nonclinical safety testing and prior human studies."
https://durangodowntown.com/events/relief-the...ata-looms/
"The clinical trial will continue to enroll patients through the anticipated early Q1 2021 announcement of top line data in order to amass as large a safety database as possible.
To date, no drug-related Serious Adverse Event has been reported in any of the ongoing studies of RLF-100, which is consistent with the absence of toxicity seen in extensive nonclinical safety testing and prior human studies."
https://durangodowntown.com/events/relief-the...ata-looms/
(0)
(0)
$MJ
